-
1
-
-
18644367900
-
Contemporary patterns of androgen deprivation use for newly diagnosed prostate cancer
-
Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Contemporary patterns of androgen deprivation use for newly diagnosed prostate cancer. Urology 2002; 60: 7-11
-
(2002)
Urology
, vol.60
, pp. 7-11
-
-
Meng, M.V.1
Grossfeld, G.D.2
Sadetsky, N.3
Mehta, S.S.4
Lubeck, D.P.5
Carroll, P.R.6
-
2
-
-
0035915453
-
Factors associated with initial therapy for clinically localized prostate cancer
-
Harlan LC, Potosky A, Gilliland FD et al. Factors associated with initial therapy for clinically localized prostate cancer. J Natl Cancer Inst 2001; 93: 1864-71
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1864-1871
-
-
Harlan, L.C.1
Potosky, A.2
Gilliland, F.D.3
-
3
-
-
0023726635
-
Hormone therapy for prostate cancer: Results of the Veterans Administration Cooperative Urological Research Group studies
-
Byar DP, Corle DK. Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies. NCI Monogr 1988; 7: 165-70
-
(1988)
NCI Monogr
, vol.7
, pp. 165-170
-
-
Byar, D.P.1
Corle, D.K.2
-
4
-
-
0031403675
-
Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial
-
The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Br J Urol 1997; 79: 235-46
-
(1997)
Br J Urol
, vol.79
, pp. 235-246
-
-
-
5
-
-
1042284728
-
Early versus delayed endocrine treatment in pN1-3M0 prostate cancer without local treatment of the primary tumor. Results of EORTC 30846 - A phase III study
-
Abstract 1487
-
Schröder FH, Kurth KH, Fossa SD et al. Early versus delayed endocrine treatment in pN1-3M0 prostate cancer without local treatment of the primary tumor. Results of EORTC 30846 - a phase III study. J Urol 2003; 169: 398 (Abstract 1487)
-
(2003)
J Urol
, vol.169
, pp. 398
-
-
Schröder, F.H.1
Kurth, K.H.2
Fossa, S.D.3
-
6
-
-
0033540004
-
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
-
Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999; 341: 1781-8
-
(1999)
N Engl J Med
, vol.341
, pp. 1781-1788
-
-
Messing, E.M.1
Manola, J.2
Sarosdy, M.3
Wilding, G.4
Crawford, E.D.5
Trump, D.6
-
7
-
-
0036845696
-
Timing of androgen deprivation for prostate cancer: Benefits versus side effects - A patient-physician dialogue
-
Soloway MS. Timing of androgen deprivation for prostate cancer: benefits versus side effects - a patient-physician dialogue. Urology 2002; 60: 735-7
-
(2002)
Urology
, vol.60
, pp. 735-737
-
-
Soloway, M.S.1
-
8
-
-
1042307986
-
Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: Results of a randomized prospective multicenter clinical trial
-
Waltregny D, Boca P, Nicolas H et al. Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a randomized prospective multicenter clinical trial. J Urol 2002; 167: 175
-
(2002)
J Urol
, vol.167
, pp. 175
-
-
Waltregny, D.1
Boca, P.2
Nicolas, H.3
-
9
-
-
0034005784
-
Intermittent androgen deprivation in prostate cancer patients: Factors predictive of prolonged time off therapy
-
Strum SB, Scholz MC, McDermed JE. Intermittent androgen deprivation in prostate cancer patients: factors predictive of prolonged time off therapy. Oncologist 2000; 5: 45-52
-
(2000)
Oncologist
, vol.5
, pp. 45-52
-
-
Strum, S.B.1
Scholz, M.C.2
McDermed, J.E.3
-
10
-
-
0033816325
-
Prolonged response to a single androgen suppression phase in a subpopulation of prostate cancer patients
-
Theyer G, Ulsperger E, Baumgartner G, Raderer M, Hamilton G. Prolonged response to a single androgen suppression phase in a subpopulation of prostate cancer patients. Ann Oncol 2000; 11: 877-81
-
(2000)
Ann Oncol
, vol.11
, pp. 877-881
-
-
Theyer, G.1
Ulsperger, E.2
Baumgartner, G.3
Raderer, M.4
Hamilton, G.5
-
11
-
-
0142228727
-
Intermittent maximal androgen blockade in patients with metastatic prostate cancer: An EORTC feasibility study
-
Albrecht W, Collette L, Fava C et al. Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study. Eur Urol 2003; 44: 505-11
-
(2003)
Eur Urol
, vol.44
, pp. 505-511
-
-
Albrecht, W.1
Collette, L.2
Fava, C.3
-
12
-
-
0033662035
-
Intermittent androgen suppression in the treatment of metastatic prostate cancer
-
Bouchot O, Lenormand L, Karam G et al. Intermittent androgen suppression in the treatment of metastatic prostate cancer. Eur Urol 2000; 38: 543-9
-
(2000)
Eur Urol
, vol.38
, pp. 543-549
-
-
Bouchot, O.1
Lenormand, L.2
Karam, G.3
-
13
-
-
0030071467
-
A prospective, randomised study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma
-
Thorpe SC, Azmatullah S, Fellows GJ, Gingell JC, O'Boyle PJ. A prospective, randomised study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma. Eur Urol 1996; 29: 47-54
-
(1996)
Eur Urol
, vol.29
, pp. 47-54
-
-
Thorpe, S.C.1
Azmatullah, S.2
Fellows, G.J.3
Gingell, J.C.4
O'Boyle, P.J.5
-
14
-
-
0033782359
-
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 Years of follow-up
-
Iversen P, Tyrrell CJ, Kaisary AV et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of follow-up. J Urol 2000; 164: 1579-82
-
(2000)
J Urol
, vol.164
, pp. 1579-1582
-
-
Iversen, P.1
Tyrrell, C.J.2
Kaisary, A.V.3
-
15
-
-
0036855879
-
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: Updated results of a multicentric trial
-
Boccardo F, Barichello M, Battaglia M et al. Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial. Eur Urol 2002; 42: 481-90
-
(2002)
Eur Urol
, vol.42
, pp. 481-490
-
-
Boccardo, F.1
Barichello, M.2
Battaglia, M.3
|